The role of interventional radiology in the management of hepatocellular carcinoma
- PMID: 24940108
- PMCID: PMC4059812
- DOI: 10.3747/co.21.1829
The role of interventional radiology in the management of hepatocellular carcinoma
Abstract
Background: Hepatocellular carcinoma (hcc) is one of the most common causes of cancer-related death worldwide. Overall, liver transplantation and resection are the only available treatments with potential for cure. Various locoregional therapies are widely used to manage patients with advanced hcc or as a bridging therapy for patients with early and intermediate disease. This article reviews and evaluates the role of interventional radiology in the management of such cases by assessing various aspects of each method, such as effect on rates of survival, recurrence, tumour response, and complications.
Methods: A systemic search of PubMed, medline, Ovid Medline In-Process, and the Cochrane Database of Systematic Reviews retrieved all related scientific papers for review.
Results: Needle core biopsy is a highly sensitive, specific, and accurate method for hcc grading. Portal-vein embolization provides adequate expansion of the future liver remnant, making more patients eligible for resection. In focal or multifocal unresectable early-stage disease, radiofrequency ablation tops all other thermoablative methods. However, microwave ablation is preferred in large tumours and in patients with Child-Pugh B disease. Cryoablation is preferred in recurrent disease and in patients who are poor candidates for anesthesia. Of the various transarterial modalities-transarterial chemoembolization (tace), drug-eluting beads, and transarterial radio-embolization (tare)-tace is the method of choice in Child-Pugh A disease, and tare is the method of choice in hcc cases with portal vein thrombosis.
Conclusions: The existing data support the importance of a multidisciplinary approach in hcc management. Large randomized controlled studies are needed to provide clear indication guidelines for each method.
Keywords: Interventional radiology; ablation; drug-eluting beads; embolization; hepatocellular carcinoma; liver biopsy.
Figures


Similar articles
-
Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.Ann Surg. 2002 Apr;235(4):466-86. doi: 10.1097/00000658-200204000-00004. Ann Surg. 2002. PMID: 11923602 Free PMC article. Review.
-
A Recent Advance in Image-Guided Locoregional Therapy for Hepatocellular Carcinoma.Gastrointest Tumors. 2016 Oct;3(2):90-102. doi: 10.1159/000445888. Epub 2016 Apr 28. Gastrointest Tumors. 2016. PMID: 27904861 Free PMC article. Review.
-
Locoregional Therapies in the Treatment of 3- to 5-cm Hepatocellular Carcinoma: Critical Review of the Literature.AJR Am J Roentgenol. 2020 Jul;215(1):223-234. doi: 10.2214/AJR.19.22098. Epub 2020 Apr 7. AJR Am J Roentgenol. 2020. PMID: 32255691 Review.
-
Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma.Adv Ther. 2016 May;33(5):699-714. doi: 10.1007/s12325-016-0324-7. Epub 2016 Apr 2. Adv Ther. 2016. PMID: 27039186 Free PMC article. Review.
-
Safety and Efficacy of Transarterial Radioembolisation in Patients with Intermediate or Advanced Stage Hepatocellular Carcinoma Refractory to Chemoembolisation.Cardiovasc Intervent Radiol. 2017 Dec;40(12):1882-1890. doi: 10.1007/s00270-017-1739-5. Epub 2017 Jul 6. Cardiovasc Intervent Radiol. 2017. PMID: 28685382
Cited by
-
Imaging Findings Within the First 12 Months of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy.Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1063-1069. doi: 10.1016/j.ijrobp.2017.08.022. Epub 2017 Aug 24. Int J Radiat Oncol Biol Phys. 2018. PMID: 29029891 Free PMC article.
-
Percutaneous transcatheter embolisation of active haemorrhage following radiofrequency ablation of hepatocellular carcinoma.BMJ Case Rep. 2016 May 26;2016:bcr2016215466. doi: 10.1136/bcr-2016-215466. BMJ Case Rep. 2016. PMID: 27229748 Free PMC article.
-
[177Lu]Lu-PSMA-617 theranostic probe for hepatocellular carcinoma imaging and therapy.Eur J Nucl Med Mol Imaging. 2023 Jul;50(8):2342-2352. doi: 10.1007/s00259-023-06155-x. Epub 2023 Mar 6. Eur J Nucl Med Mol Imaging. 2023. PMID: 36877233
-
Liver targeted therapies for hepatocellular carcinoma prior to transplant: contemporary management strategies.Glob Surg. 2018 Apr;4(1):10.15761/GOS.1000171. doi: 10.15761/GOS.1000171. Epub 2018 Feb 15. Glob Surg. 2018. PMID: 29782618 Free PMC article.
-
MRI Assessment of Hepatocellular Carcinoma after Local-Regional Therapy: A Comprehensive Review.Radiol Imaging Cancer. 2020 Jan 31;2(1):e190024. doi: 10.1148/rycan.2020190024. eCollection 2020 Jan. Radiol Imaging Cancer. 2020. PMID: 33778692 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous